| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-124 |
Sentence |
denotes |
Cryptic sialic acid binding lectins on human blood leukocytes can be unmasked by sialidase treatment or cellular activation. |
| T1 |
0-124 |
Sentence |
denotes |
Cryptic sialic acid binding lectins on human blood leukocytes can be unmasked by sialidase treatment or cellular activation. |
| T1 |
0-124 |
Sentence |
denotes |
Cryptic sialic acid binding lectins on human blood leukocytes can be unmasked by sialidase treatment or cellular activation. |
| TextSentencer_T2 |
125-319 |
Sentence |
denotes |
We recently reported that the sialic acid-specific binding sites of CD22 molecules on B cells are masked by endogenous ligands, and can be unmasked by sialidase treatment or cellular activation. |
| T2 |
125-319 |
Sentence |
denotes |
We recently reported that the sialic acid-specific binding sites of CD22 molecules on B cells are masked by endogenous ligands, and can be unmasked by sialidase treatment or cellular activation. |
| T2 |
125-319 |
Sentence |
denotes |
We recently reported that the sialic acid-specific binding sites of CD22 molecules on B cells are masked by endogenous ligands, and can be unmasked by sialidase treatment or cellular activation. |
| TextSentencer_T3 |
320-464 |
Sentence |
denotes |
Here, we show that many other human blood leukocyte types have endogenous sialic acid binding sites that can be unmasked by sialidase treatment. |
| T3 |
320-464 |
Sentence |
denotes |
Here, we show that many other human blood leukocyte types have endogenous sialic acid binding sites that can be unmasked by sialidase treatment. |
| T3 |
320-464 |
Sentence |
denotes |
Here, we show that many other human blood leukocyte types have endogenous sialic acid binding sites that can be unmasked by sialidase treatment. |
| TextSentencer_T4 |
465-654 |
Sentence |
denotes |
Truncation of sialic acid side chains on the soluble probes used for detection abolishes all binding, indicating the specificity of the interaction for the details of sialic acid structure. |
| T4 |
465-654 |
Sentence |
denotes |
Truncation of sialic acid side chains on the soluble probes used for detection abolishes all binding, indicating the specificity of the interaction for the details of sialic acid structure. |
| T4 |
465-654 |
Sentence |
denotes |
Truncation of sialic acid side chains on the soluble probes used for detection abolishes all binding, indicating the specificity of the interaction for the details of sialic acid structure. |
| TextSentencer_T5 |
655-889 |
Sentence |
denotes |
There is limited overlap between alpha2-6- and alpha2-3-sialic acid-specific binding sites, which are unmasked on monocytes, natural killer cells, a minority of mature T cells, neutrophils, and some cultured human leukemic cell lines. |
| T5 |
655-889 |
Sentence |
denotes |
There is limited overlap between alpha2-6- and alpha2-3-sialic acid-specific binding sites, which are unmasked on monocytes, natural killer cells, a minority of mature T cells, neutrophils, and some cultured human leukemic cell lines. |
| T5 |
655-889 |
Sentence |
denotes |
There is limited overlap between alpha2-6- and alpha2-3-sialic acid-specific binding sites, which are unmasked on monocytes, natural killer cells, a minority of mature T cells, neutrophils, and some cultured human leukemic cell lines. |
| TextSentencer_T6 |
890-1105 |
Sentence |
denotes |
Activation with phorbol ester and calcium ionophore causes spontaneous exposure of some of the binding sites, occurring over a period of minutes on neutrophils and several hours on monocytes and U937 leukemia cells. |
| T6 |
890-1105 |
Sentence |
denotes |
Activation with phorbol ester and calcium ionophore causes spontaneous exposure of some of the binding sites, occurring over a period of minutes on neutrophils and several hours on monocytes and U937 leukemia cells. |
| T6 |
890-1105 |
Sentence |
denotes |
Activation with phorbol ester and calcium ionophore causes spontaneous exposure of some of the binding sites, occurring over a period of minutes on neutrophils and several hours on monocytes and U937 leukemia cells. |
| TextSentencer_T7 |
1106-1193 |
Sentence |
denotes |
Activation is accompanied by some evidence for desialylation of cell surface molecules. |
| T7 |
1106-1193 |
Sentence |
denotes |
Activation is accompanied by some evidence for desialylation of cell surface molecules. |
| T7 |
1106-1193 |
Sentence |
denotes |
Activation is accompanied by some evidence for desialylation of cell surface molecules. |
| TextSentencer_T8 |
1194-1309 |
Sentence |
denotes |
Thus, many human blood cells have specific binding sites for sialic acids, masked by endogenous sialylated ligands. |
| T8 |
1194-1309 |
Sentence |
denotes |
Thus, many human blood cells have specific binding sites for sialic acids, masked by endogenous sialylated ligands. |
| T8 |
1194-1309 |
Sentence |
denotes |
Thus, many human blood cells have specific binding sites for sialic acids, masked by endogenous sialylated ligands. |
| TextSentencer_T9 |
1310-1404 |
Sentence |
denotes |
Cellular activation can unmask these sites, possibly by the action of an endogenous sialidase. |
| T9 |
1310-1404 |
Sentence |
denotes |
Cellular activation can unmask these sites, possibly by the action of an endogenous sialidase. |
| T9 |
1310-1404 |
Sentence |
denotes |
Cellular activation can unmask these sites, possibly by the action of an endogenous sialidase. |
| TextSentencer_T10 |
1405-1571 |
Sentence |
denotes |
The nearly universal masking of such sites in unactivated blood cells could explain why many of these sialic acid-binding lectins have not been previously discovered. |
| T10 |
1405-1571 |
Sentence |
denotes |
The nearly universal masking of such sites in unactivated blood cells could explain why many of these sialic acid-binding lectins have not been previously discovered. |
| T10 |
1405-1571 |
Sentence |
denotes |
The nearly universal masking of such sites in unactivated blood cells could explain why many of these sialic acid-binding lectins have not been previously discovered. |
| TextSentencer_T11 |
1572-1668 |
Sentence |
denotes |
Similar considerations may apply to sialic acid binding lectins of other cell types and tissues. |
| T11 |
1572-1668 |
Sentence |
denotes |
Similar considerations may apply to sialic acid binding lectins of other cell types and tissues. |
| T11 |
1572-1668 |
Sentence |
denotes |
Similar considerations may apply to sialic acid binding lectins of other cell types and tissues. |